Illinois General Assembly - Bill Status for HB0156
Illinois General Assembly

  Bills & Resolutions  
  Compiled Statutes  
  Public Acts  
  Legislative Reports  
  IL Constitution  
  Legislative Guide  
  Legislative Glossary  

 Search By Number
 (example: HB0001)
Search Tips

Search By Keyword

 Bill Status of HB0156  102nd General Assembly


Short Description:  BIOLOGICAL PRODUCTS-DRUG PRICE

House Sponsors
Rep. Michael J. Zalewski - LaToya Greenwood - Sonya M. Harper - Will Guzzardi, Dan Caulkins, Debbie Meyers-Martin, Theresa Mah, Carol Ammons, Delia C. Ramirez, Celina Villanueva, Sara Feigenholtz, Gregory Harris, Robyn Gabel, Kelly M. Cassidy, Ann M. Williams, Robert Martwick, Anna Moeller, Anne Stava-Murray, Jennifer Gong-Gershowitz, Lamont J. Robinson, Jr., Joyce Mason, Aaron M. Ortiz and Camille Y. Lilly

Senate Sponsors
(Sen. Emil Jones, III - John J. Cullerton - Jacqueline Y. Collins - Pat McGuire and David Koehler)

Last Action
DateChamber Action
  4/2/2021HousePublic Act . . . . . . . . . 101-0660

Statutes Amended In Order of Appearance
New Act
5 ILCS 140/7.5
215 ILCS 5/356z.33 new
225 ILCS 85/16d new
225 ILCS 85/19.5
225 ILCS 85/19.7 new
225 ILCS 85/25from Ch. 111, par. 4145
225 ILCS 85/41


Synopsis As Introduced
Creates the Prescription Drug Pricing Transparency Act. Requires health insurers to disclose certain rate and spending information concerning prescription drugs and certain prescription drug pricing information to the Department of Public Health. Requires the Department and health insurers to create annual lists of prescription drugs on which the State spends significant health care dollars and for which costs have increased at a certain rate over time. Requires the Department and health insurers to provide their lists to the Attorney General. Requires prescription drug manufacturers to notify the Attorney General if they are introducing a new prescription drug at a wholesale acquisition cost that exceeds the threshold set for a specialty drug under the Medicare Part D program. Amends the Illinois Insurance Code. Requires a group or individual policy of accident and health insurance that provides coverage for prescription drugs to apply the same cost-sharing requirements to interchangeable biological products as apply to generic drugs under the policy. Amends the Pharmacy Practice Act. Provides that when a pharmacist receives a prescription for a biological product, the pharmacist shall select the lowest priced interchangeable biological product (rather than allowing a pharmacist to substitute an interchangeable biological product only if certain requirements are met). Requires that when a pharmacist receives a prescription from a Medicaid recipient, the pharmacist shall select the preferred drug or biological product from the State's preferred drug list. Makes other changes. Makes conforming changes in the Freedom of Information Act. Effective immediately.

House Committee Amendment No. 1
Deletes reference to:
215 ILCS 5/356z.33
225 ILCS 85/16d new
225 ILCS 85/19.5
225 ILCS 85/19.7 new
225 ILCS 85/25
225 ILCS 85/41

Removes the provisions amending the Illinois Insurance Code and the Pharmacy Practice Act.

 State Mandates Fiscal Note, House Committee Amendment No. 1 (Dept. of Commerce & Economic Opportunity)
 This bill does not create a State mandate.

Senate Floor Amendment No. 3
Deletes reference to:
New Act
5 ILCS 140/7.5
Adds reference to:
625 ILCS 57/33 new
625 ILCS 57/Act title
625 ILCS 57/1
625 ILCS 57/5
625 ILCS 57/10
625 ILCS 57/15
625 ILCS 57/20
625 ILCS 57/25
625 ILCS 57/30
625 ILCS 57/32
625 ILCS 57/34

Replaces everything after the enacting clause. Reenacts the Transportation Network Providers Act. Provides for the continuation and validation of the Act, and extends the repeal to June 1, 2021. Effective immediately.

Actions 
DateChamber Action
  12/10/2018HousePrefiled with Clerk by Rep. Mary E. Flowers
  1/9/2019HouseFirst Reading
  1/9/2019HouseReferred to Rules Committee
  1/29/2019HouseAssigned to Prescription Drug Affordability & Accessibility Committee
  2/7/2019HouseAdded Chief Co-Sponsor Rep. LaToya Greenwood
  2/14/2019HouseAdded Chief Co-Sponsor Rep. Michael J. Zalewski
  2/14/2019HouseRemove Chief Co-Sponsor Rep. Michael J. Zalewski
  3/8/2019HouseAdded Co-Sponsor Rep. Dan Caulkins
  3/15/2019HouseAdded Co-Sponsor Rep. Debbie Meyers-Martin
  3/21/2019HouseHouse Committee Amendment No. 1 Filed with Clerk by Rep. Mary E. Flowers
  3/21/2019HouseHouse Committee Amendment No. 1 Referred to Rules Committee
  3/26/2019HouseHouse Committee Amendment No. 1 Rules Refers to Prescription Drug Affordability & Accessibility Committee
  3/27/2019HouseHouse Committee Amendment No. 1 Adopted in Prescription Drug Affordability & Accessibility Committee; by Voice Vote
  3/27/2019HouseDo Pass as Amended / Short Debate Prescription Drug Affordability & Accessibility Committee; 011-006-000
  3/29/2019HousePlaced on Calendar 2nd Reading - Short Debate
  4/1/2019HouseHouse Committee Amendment No. 1 Fiscal Note Requested as Amended by Rep. Tom Demmer
  4/4/2019HouseAdded Chief Co-Sponsor Rep. Sonya M. Harper
  4/4/2019HouseRemove Chief Co-Sponsor Rep. Michael Halpin
  4/10/2019HouseSecond Reading - Short Debate
  4/10/2019HouseHeld on Calendar Order of Second Reading - Short Debate
  4/11/2019HouseHouse Committee Amendment No. 1 State Mandates Fiscal Note Filed as Amended
  4/11/2019HouseAdded Co-Sponsor Rep. Theresa Mah
  4/11/2019HouseAdded Co-Sponsor Rep. Carol Ammons
  4/11/2019HouseAdded Co-Sponsor Rep. Delia C. Ramirez
  4/11/2019HouseAdded Co-Sponsor Rep. Celina Villanueva
  4/11/2019HouseAdded Co-Sponsor Rep. Sara Feigenholtz
  4/11/2019HouseAdded Co-Sponsor Rep. Gregory Harris
  4/11/2019HouseAdded Co-Sponsor Rep. Robyn Gabel
  4/11/2019HouseAdded Co-Sponsor Rep. Kelly M. Cassidy
  4/11/2019HouseAdded Co-Sponsor Rep. Ann M. Williams
  4/11/2019HouseAdded Co-Sponsor Rep. Robert Martwick
  4/11/2019HouseAdded Co-Sponsor Rep. Anna Moeller
  4/11/2019HouseAdded Co-Sponsor Rep. Anne Stava-Murray
  4/11/2019HouseAdded Co-Sponsor Rep. Jennifer Gong-Gershowitz
  4/11/2019HouseAdded Co-Sponsor Rep. Lamont J. Robinson, Jr.
  4/11/2019HouseAdded Co-Sponsor Rep. Joyce Mason
  4/11/2019HouseAdded Co-Sponsor Rep. Aaron M. Ortiz
  4/12/2019HouseHouse Committee Amendment No. 1 Note / Motion Filed - Note Act Does Not Apply Rep. Mary E. Flowers
  4/12/2019HouseMotion Prevailed 069-039-000
  4/12/2019HouseFiscal Note Request is Inapplicable
  4/12/2019HousePlaced on Calendar Order of 3rd Reading - Short Debate
  4/12/2019HouseThird Reading - Short Debate - Passed 065-041-000
  4/12/2019HouseAdded Chief Co-Sponsor Rep. Will Guzzardi
  4/12/2019HouseAdded Co-Sponsor Rep. Camille Y. Lilly
  4/12/2019SenateArrive in Senate
  4/12/2019SenatePlaced on Calendar Order of First Reading
  4/12/2019SenateChief Senate Sponsor Sen. Antonio Muñoz
  4/12/2019SenateFirst Reading
  4/12/2019SenateReferred to Assignments
  4/12/2019SenateAdded as Alternate Chief Co-Sponsor Sen. Jacqueline Y. Collins
  4/12/2019SenateAdded as Alternate Chief Co-Sponsor Sen. John G. Mulroe
  4/19/2019SenateAdded as Alternate Co-Sponsor Sen. David Koehler
  4/22/2019SenateAlternate Chief Sponsor Changed to Sen. John G. Mulroe
  4/24/2019SenateAssigned to Insurance
  4/24/2019SenateAdded as Alternate Chief Co-Sponsor Sen. Pat McGuire
  4/30/2019SenateAdded as Alternate Co-Sponsor Sen. Sue Rezin
  5/1/2019SenatePostponed - Insurance
  5/3/2019SenateSponsor Removed Sen. Sue Rezin
  5/9/2019SenatePostponed - Insurance
  5/10/2019SenateRule 2-10 Committee Deadline Established As May 17, 2019
  5/17/2019SenateRule 3-9(a) / Re-referred to Assignments
  6/21/2019SenateAlternate Chief Sponsor Changed to Sen. John J. Cullerton
  11/27/2019SenateAdded as Alternate Chief Co-Sponsor Sen. Andy Manar
  12/3/2019SenateAlternate Chief Sponsor Changed to Sen. Andy Manar
  12/3/2019SenateAdded as Alternate Chief Co-Sponsor Sen. John J. Cullerton
  1/5/2021SenateApproved for Consideration Assignments
  1/5/2021SenatePlaced on Calendar Order of 2nd Reading January 10, 2021
  1/5/2021SenateRule 2-10 Committee/3rd Reading Deadline Established As January 13, 2021
  1/10/2021SenateAlternate Chief Sponsor Changed to Sen. Emil Jones, III
  1/10/2021SenateSenate Floor Amendment No. 1 Filed with Secretary by Sen. Emil Jones, III
  1/10/2021SenateSenate Floor Amendment No. 1 Referred to Assignments
  1/10/2021SenateSecond Reading
  1/10/2021SenatePlaced on Calendar Order of 3rd Reading January 11, 2021
  1/11/2021SenateSenate Floor Amendment No. 2 Filed with Secretary by Sen. Emil Jones, III
  1/11/2021SenateSenate Floor Amendment No. 2 Referred to Assignments
  1/11/2021SenateSenate Floor Amendment No. 3 Filed with Secretary by Sen. Emil Jones, III
  1/11/2021SenateSenate Floor Amendment No. 3 Referred to Assignments
  1/11/2021SenateSenate Floor Amendment No. 3 Be Approved for Consideration Assignments
  1/12/2021SenateRecalled to Second Reading
  1/12/2021SenateSenate Floor Amendment No. 3 Adopted; Jones
  1/12/2021SenatePlaced on Calendar Order of 3rd Reading
  1/12/2021SenateThird Reading - Passed; 054-000-000
  1/12/2021SenateSenate Floor Amendment No. 1 Tabled Pursuant to Rule 5-4(a)
  1/12/2021SenateSenate Floor Amendment No. 2 Tabled Pursuant to Rule 5-4(a)
  1/12/2021HouseArrived in House
  1/12/2021HousePlaced on Calendar Order of Concurrence Senate Amendment(s) 3
  1/12/2021HouseChief Sponsor Changed to Rep. Michael J. Zalewski
  1/12/2021HouseSenate Floor Amendment No. 3 Motion Filed Concur Rep. Michael J. Zalewski
  1/12/2021HouseSenate Floor Amendment No. 3 Motion to Concur Referred to Rules Committee
  1/12/2021HouseSenate Floor Amendment No. 3 Motion to Concur Recommends Be Adopted Rules Committee; 005-000-000
  1/13/2021HouseSenate Floor Amendment No. 3 House Concurs 109-000-000
  1/13/2021HouseHouse Concurs
  1/13/2021HousePassed Both Houses
  2/4/2021HouseSent to the Governor
  4/2/2021HouseGovernor Approved
  4/2/2021HouseEffective Date April 2, 2021
  4/2/2021HousePublic Act . . . . . . . . . 101-0660

Back To Top